Clinical Trials

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms

NCT03804255 2026-05-06

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Withdrawn

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT04316117 2026-05-05

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT05076266 2026-05-05

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Terminated

14 enrolled 10 charts

Breast Neoplasms

NCT00802711 2026-04-13

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Phase NA Terminated

6 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Phase 2 Completed

180 enrolled 14 charts

Breast Neoplasms

NCT03843346 2026-04-13

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

Completed

87 enrolled

Breast Neoplasms

NCT04650581 2026-04-13

FINER

250 enrolled 13 charts

Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Phase 3 Completed

5,187 enrolled

Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

93 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03568422 2026-03-27

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

37 enrolled 14 charts

Breast Neoplasms

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

2,354 enrolled 29 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

231 enrolled

Breast Neoplasms

NCT07425002 2026-02-20

PRISM

1,600 enrolled

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

15 enrolled 7 charts

Breast Neoplasms

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Phase NA Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT02308085 2026-02-09

POSITIVE

518 enrolled

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast Neoplasms

NCT07380971 2026-02-02

Developing a Comprehensive Exercise Service for Breast Cancer Process

Recruiting

200 enrolled

Breast Neoplasms, Motor Activity

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

51 enrolled

Breast Neoplasms

NCT06995443 2026-01-30

REGAIN

200 enrolled

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT01840293 2025-12-19

Breast Cancer Proteomics and Molecular Heterogeneity

Recruiting

1,780 enrolled

Breast Neoplasms

NCT02050750 2025-12-19

TAILORx Tissue Bank

Active not recruiting

600 enrolled

Breast Neoplasms

NCT07084558 2025-10-28

TEODOR

350 enrolled

Breast Neoplasms

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Phase 3 Recruiting

491 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT03820063 2025-09-19

TRAIN-3

462 enrolled

Breast Neoplasms

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast Neoplasms

NCT05856773 2025-09-09

COMPRO

Phase 3 Recruiting

276 enrolled

Breast Neoplasms

NCT01758445 2025-09-04

Proton Radiation for Stage II/III Breast Cancer

220 enrolled

Breast Neoplasms, Neoplasms

NCT06462963 2025-08-01

SPRINT

BreastGastrointestinalGenitourinary

302 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

3,294 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT04042051 2025-07-22

Panthera

Phase 1 Terminated

2 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00963417 2025-07-14

TEXT-Bone

Phase NA Completed

119 enrolled

Breast Neoplasms, Osteoporosis

NCT01722851 2025-07-08

Circulating miRNAs.

Completed

255 enrolled

Breast Neoplasms, Recurrence

NCT01726322 2025-07-08

Ovarian Reserve in Premenopausal Breast Cancer

Terminated

216 enrolled

Breast Neoplasms

NCT01840306 2025-07-08

Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

Completed

330 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT01824836 2025-05-31

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

1,046 enrolled 15 charts